JMP Securities analyst Silvan Tuerkcan reiterates Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and maintains $21 price target.
- Headlines
- JMP Securities Reiterates Market Outperform on Relay Therapeutics, Maintains $21 Price Target
JMP Securities Reiterates Market Outperform on Relay Therapeutics, Maintains $21 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
05:22
Natixis Bank: It is expected that the Federal Reserve will adopt a hawkish interest rate cut policy, and the bank may "open the door for pausing further rate cuts, but the duration of the pause is uncertain."
05:21
The German Alternative for Germany (AfD) party stated that Germany could withdraw from NATO if it does not respect the interests of the Russian Federation.
05:18
Attacks occurred in two locations in western Sudan, resulting in dozens of deaths.